Eli Musser is a New Yorker who contracted COVID-19 in March 2020. He suffered relentless symptoms ever since, including seizures, night sweats, panic attacks and insomnia.
In February of this year he started a 90 FDA day trial for 56 people suffering from COVID Long-Haulers with the drug Leronlimab. The trial has been successful so far with Eli feeling better than he has in over a year.